Untitled 3

Source R&D is the authoritative source of technology and services information supporting pharmaceutical and biotechnology companies in their drug discovery and development research projects.

Source R&D features extensive listings of service providers classified under company or organisation type, including contract chemical manufacturers; contract biologics manufacturers; biological research companies and organisations; and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

The extensive coverage of Source R&D and the support of life sciences organisations One Nucleus and Bionow make it an invaluable reference tool that streamlines the vendor selection process to bring pharmaceutical/biotechnology companies and suppliers together.

Simplifying high content screening with the VIAFLO 96

INTEGRA Biosciences’ VIAFLO 96 electronic multi-channel pipetting system is helping biotechnology company HCS Pharma to improve the reproducibility of high content screening using its patented BIOMIMESYS 3D cell culture technology. Elodie Vandenhaute, Study Director at HCS Pharma, explained: “96-well cell…
  • Published in Source R&D
  • Read: 40 times

Polyplus-transfection introduces new nanoparticle DNA transfection reagent

Polyplus-transfection SA, a developer of innovative solutions for the delivery of nucleic acids in research, bioproduction and therapeutics, has introduced jetOPTIMUS, a new reagent for powerful nanoparticle DNA transfection. “As cell and gene therapies become more advanced and complex, this…
  • Published in Source R&D
  • Read: 51 times

Scientists develop panel of recombinant human snake venom antibodies

UK-headquartered IONTAS Limited, a company specialising in the discovery and optimisation of fully human antibodies, has published a research paper in Nature Communications in collaboration with the Technical University of Denmark and the Instituto Clodomiro Picado of the University of…
  • Published in Source R&D
  • Read: 59 times

Endomag lymphatic mapping device receives FDA approval

Surgical guidance specialist Endomag has received premarket approval from the FDA for Magtrace, the first non-radioactive, dual-tracer for lymphatic mapping in patients with breast cancer undergoing a mastectomy. Magtrace is a liquid marker designed to follow the route that cancer…
  • Published in Source R&D
  • Read: 130 times

Irvine Scientific now offers Falcon IVF products in the US

Cell culture media development and manufacturing specialist Irvine Scientific has established a new agreement with Corning Incorporated giving Irvine Scientific US distribution rights for Corning’s Falcon range of IVF dishes and plates. All Falcon IVF plasticware is manufactured from crystalline…
  • Published in Source R&D
  • Read: 143 times

Bio-Rad launches anti-ranibizumab antibodies

Bio-Rad Laboratories, Inc has launched a range of recombinant monoclonal anti-ranibizumab antibodies that are highly specific for the monoclonal antibody drug ranibizumab (Lucentis) or the complex of ranibizumab with its target, vascular endothelial growth factor A (VEGF-A). Ranibizumab is used…
  • Published in Source R&D
  • Read: 169 times

Irvine Scientific introduces chemically-defined natural killer cell expansion medium for immunotherapy and translational research applications

Cell culture media specialist Irvine Scientific has introduced PRIME-XV® NK Cell CDM as the first commercially available chemically-defined (CDM), animal component-free (ACF) medium for the ex-vivo expansion of NK cells while preserving cell potency and functionality. Current approaches to immunotherapy focus…
  • Published in Source R&D
  • Read: 192 times
Subscribe to this RSS feed